Target Details
| UniProt AC | P42345 |
|---|---|
| Gene Symbol | MTOR |
| Protein Name | Serine/threonine-protein kinase mTOR |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF02259 (FAT) PF02260 (FATC) PF08771 (FRB_dom) PF23593 (HEAT_ATR) PF11865 (mTOR_dom) PF00454 (PI3_PI4_kinase) |
Summary
- Multi-target molecules 2,517
- Clinical molecules 193
- Avg pChEMBL 7.75
KEGG Pathways (53)
- AMPK signaling pathway
- Acute myeloid leukemia
- Adipocytokine signaling pathway
- Alzheimer disease
- Amyotrophic lateral sclerosis
- Apelin signaling pathway
- Autophagy - animal
- Autophagy - other
- Breast cancer
- Cellular senescence
- Central carbon metabolism in cancer
- Chemical carcinogenesis - receptor activation
- Choline metabolism in cancer
- Colorectal cancer
- Diabetic cardiomyopathy
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- ErbB signaling pathway
- Gastric cancer
- Glioma
- Growth hormone synthesis, secretion and action
- HIF-1 signaling pathway
- Hepatocellular carcinoma
- Herpes simplex virus 1 infection
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- Human papillomavirus infection
- Huntington disease
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- JAK-STAT signaling pathway
- Kaposi sarcoma-associated herpesvirus infection
- Longevity regulating pathway
- Longevity regulating pathway - multiple species
- Lysosome biogenesis
- MicroRNAs in cancer
- Neutrophil extracellular trap formation
- PD-L1 expression and PD-1 checkpoint pathway in cancer
- PI3K-Akt signaling pathway
- Pancreatic cancer
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Phospholipase D signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Shigellosis
- Spinocerebellar ataxia
- Th17 cell differentiation
- Thermogenesis
- Thyroid hormone signaling pathway
- Type II diabetes mellitus
- mTOR signaling pathway
Associated Diseases (2)
Active Molecules (2,517)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
JBMNBUBDMUJKLS
|
8.8 | Ki | 2 | — | |
JXXSTUWGDVXVLU
|
8.8 | IC50 | 2 | — | |
NSQFPKSOLJYGEX
|
8.8 | IC50 | 2 | — | |
QJJXYPPXXYFBGM
|
8.8 | IC50 | 11 | — | |
WRJSXCWYFAJORN
|
8.8 | Ki | 2 | — | |
BQFCMZRCBOMMDE
|
8.8 | Ki | 2 | — | |
CEWBWRHLEANWFL
|
8.8 | IC50 | 2 | — | |
LYWAOJLWRHFVIR
|
8.8 | IC50 | 2 | — | |
WDUHBSJUNVATLX
|
8.8 | Ki | 2 | — | |
BPPQVJDWSGXVBZ
|
8.7 | IC50 | 2 | — | |
GUFVTKTWKYLOQP
|
8.7 | IC50 | 7 | — | |
LOSCOCADDAFDQI
|
8.7 | IC50 | 2 | — | |
LPCFSKYWYNICAE
|
8.7 | IC50 | 2 | — | |
PECPVXATHUSMDW
|
8.7 | IC50 | 2 | — | |
RGVKBHWXKPSTNQ
|
8.7 | IC50 | 3 | — | |
ZJGZMIKREDOSOI
|
8.7 | IC50 | 2 | — | |
LRWLSMIVBWZTPN
|
8.7 | IC50 | 2 | — | |
WOQDAYPPCSYMGN
|
8.7 | IC50 | 3 | — | |
XCYCFPLMANGNRK
|
8.7 | IC50 | 2 | — | |
HMSOYXYBLZNHIF
|
8.7 | IC50 | 2 | — | |
MIPSHXJPVYIDDC
|
8.7 | IC50 | 3 | — | |
OZDCJUMRPCRCIW
|
8.7 | IC50 | 2 | — | |
UPQRSQYXPGPCQM
|
8.7 | IC50 | 2 | — | |
ZFFYRSOJDYAHTC
|
8.7 | IC50 | 3 | — | |
DZOSRKCJZGPFRH
|
8.7 | IC50 | 2 | — | |
ORTXPRAWDPZQKG
|
8.7 | IC50 | 2 | — | |
OYXDADGCFDOKLT
|
8.7 | Ki | 2 | — | |
QRJAMQLBQFQSCP
|
8.7 | Ki | 2 | — | |
AYBCLTUZHMNRNR
|
8.7 | IC50 | 2 | — | |
BBDRIYWPYVGCQJ
|
8.7 | IC50 | 2 | — | |
BIKQHHNLLORGLD
|
8.7 | Kd | 5 | — | |
CGNXSGOKSFKHPY
|
8.7 | IC50 | 2 | — | |
CTJNIFLTSURJEP
|
8.7 | IC50 | 2 | — | |
DQBWVSRNMDACJQ
|
8.7 | IC50 | 2 | — | |
DZLWBRXUDBZZHQ
|
8.7 | IC50 | 2 | — | |
FDFYQLVTMBNTHI
|
8.7 | IC50 | 2 | — | |
FNDQHZLQGMPQRZ
|
8.7 | IC50 | 2 | — | |
FORRJTNZMAPPFV
|
8.7 | IC50 | 2 | — | |
GBOUQEZUBKMLLZ
|
8.7 | IC50 | 2 | — | |
IDFNAKGDSYLTBM
|
8.7 | IC50 | 2 | — | |
IYBMOXXTNOCCOV
|
8.7 | IC50 | 3 | — | |
JDISKXJUJCCGMT
|
8.7 | IC50 | 3 | — | |
JKXOLXCONZYUPX
|
8.7 | IC50 | 2 | — | |
JQXHYLREINFLSA
|
8.7 | IC50 | 2 | — | |
KGCKZWITSURBGM
|
8.7 | IC50 | 2 | — | |
KLUZJISAVWPGMS
|
8.7 | IC50 | 2 | — | |
KUWGSNAXZXLPHP
|
8.7 | IC50 | 2 | — | |
KWDQVRBTEKHDMN
|
8.7 | IC50 | 2 | — | |
LAIACFMZANZCBH
|
8.7 | IC50 | 2 | — | |
MPZUHFMONDTNMH
|
8.7 | IC50 | 4 | — |